Erica Lyndrup Herzog MD, PhD

Associate Professor of Medicine (Pulmonary); Director, Translational Lung Research Program; Co-Director, Yale Fibrosis Program; Assistant Director, Medical Student Research, Department of Medicine; Director, Interstitial Lung Disease Center of Excellence

Clinical Interests

Interstitial lung disease, idiopathic pulmonary fibrosis, scleroderma, sarcoidosis, diffuse parenchymal lung disease


Board Certifications

2006
Critical Care Medicine, Board Certified
2004
Pulmonary Disease, Board Certified

Patient Care Locations

erica_herzogfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Rheumatoid ArthritisInnate Immune Responsiveness in the Elderly and the Immunosuppressed
Alpha 1 Antitrypsin Deficiency and AATD(GRADS)(A) - Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis
Idiopathic Pulmonary Fibrosis(RAINIER) A Phase 2, Randomized, Double Blind, Placebo Controlled, Multi-Center Study to Assess the Efficacy and safety of GS-6624 in Subjects with Idiopathic Pulmonary Fibrosis (GS-US-322-027)
Sarcoidosis(GRADS)(B) - Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidsosis
Idiopathic Pulmonary Fibrosis(GB28547) A Phase II, Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy and Safety of Lebrikizumab in Patients with Idiopathic Pulmonary Fibrosis

More Clinical Trials...

Edit Profile